This pathway, due to its role in a wide range of key cellular processes, has been intensely studied for its involvement in tumor initiation and progression and is frequently dysregulated in cancer through the increased expression and/or activation of receptor tyrosine kinases, mutations in pathway components, or the loss of negative pathway regulators. Here, NTRK1 is linked to cancer.